Showing 104 of 104on this page. Filters & sort apply to loaded results; URL updates for sharing.104 of 104 on this page
Genentech is reintroducing SUSVIMO implant for wet AMD in the US
Genentech to Reintroduce Susvimo for Wet Age-related Macular ...
Genentech Executive Discusses Vabysmo Pre-Filled Syringe and Susvimo ...
Genentech Provides 2-year, Phase 3 Data for Vabysmo and Susvimo - Eyewire+
La FDA approuve Susvimo de Genentech pour la rétinopathie diabétique ...
Genentech Relaunches Susvimo for Wet Age-Related Macular Degeneration
Genentech announces 5-Year data of susvimo for wet AMD from Portal study
Genentech receives FDA approval to relaunch Susvimo | Ophthalmology Times
Genentech Issues Voluntary Recall of Susvimo Ocular Implant for Wet AMD ...
Genentech to launch Susvimo for wet AMD | Venus King posted on the ...
Genentech receives FDA approval to relaunch Susvimo | Modern Retina
Genentech Unveils Second Chance for Susvimo to Combat AMD
VIDEO: Genentech shares positive study data ahead of Susvimo relaunch
Genentech Announces Reintroduction of Susvimo for Wet AMD | HCPLive
Genentech Recalls Susvimo Implant After Finding Seal Can Leak | Market ...
Genentech to Reintroduce Susvimo Ocular Implant for Wet AMD
Susvimo Approved for Patients With Diabetic Retinopathy - Optometry Advisor
VM - FDA Approves Genentech’s Susvimo for the Treatment of Diabetic ...
FDA Expands Label for Genentech's Susvimo Implant to Include DR - Eyewire+
Susvimo (Genentech, Inc.): FDA Package Insert, Page 7
Genentech, Roche Recall Ophthalmology Biobetter Susvimo
FDA approves Susvimo continuous drug delivery implant for AMD - Insight
Genentech’s Susvimo earns FDA approval | Modern Retina
FDA clears Roche's Susvimo implant for eye disease wet AMD | pharmaphorum
FDA Approves Genentech’s Susvimo for Diabetic Retinopathy | Pienomial
Susvimo® (ranibizumab injection) | Genentech Prescribing & Product ...
New two-year data for Vabysmo and Susvimo reinforce potential to ...
FDA Approves Susvimo (ranibizumab) for the Treatment of Wet Age-Related ...
Susvimo (Genentech, Inc.): FDA Package Insert, Page 6
Susvimo (Genentech, Inc.): FDA Package Insert
Susvimo Implant Re-enters US Market for Treatment of Wet AMD
Susvimo - Genentech, Inc.
FDA Approves Roche's Susvimo for Diabetic Retinopathy - Media MICE
Genentech’s Susvimo receives new FDA indication for diabetic retinopathy
Genentech’s Susvimo Gains FDA Approval for Diabetic Macular Edema ...
Genentech’s Susvimo receives FDA approval | Ophthalmology Times ...
Susvimo Approved for Wet Age-Related Macular Degeneration - MPR
Genentech Provides Update on Astegolimab in Chronic Obstructive ...
The FDA approves a label expansion for Genentech’s Susvimo implant ...
Susvimo (Genentech, Inc.): FDA Package Insert, Page 2
Genentech’s Susvimo receives new FDA indication for diabetic ...
Genetech Susvimo (ranibizumab injection) Monograph - Guideline Central
SUSVIMO® (ranibizumab injection) | Contact Genentech
FDA Approves Susvimo for DR | Retinal Physician
SUSVIMO (ocular implant - ranibizumab) - Macula Retina Vitreous Center
Genentech’s Susvimo Gets FDA Nod as Continuous Delivery Treatment for ...
FDA Approves Genentech's Susvimo for Diabetic Retinopathy
SUSVIMO - Genentech, Inc. Trademark Registration
FDA Approval of Genentech’s Susvimo for Diabetic Retinopathy | MCQs ...
FDA Approves Genentech's Susvimo for Diabetic Retinopathy | INN
Genentech's Susvimo receives new FDA indication for diabetic retinopathy
New five-year data on Susvimo implant for nAMD - Insight
Susvimo Implant to Return to Market Following Recall
Genentech Unveils Positive Phase II Results for the First-Ever Eye ...
New 2-Year Data for Genentech’s Vabysmo and Susvimo Show Potential of ...
SUSVIMO™ (ranibizumab injection) | Contact Genentech
Thank you to our outstanding partners at Genentech for the opportunity ...
FDA Approves Genentech’s Port Delivery System, Susvimo, a First-of-Its ...
Glance by Eyes On Eyecare | Read the Latest Eyecare Industry News
FDA Approves Genentech's Port Delivery System, Susvimo, for Wet AMD ...
Genentech: Susvimo® (ranibizumab injection) - Information for ...
Favorable Long-Term Results With Ranibizumab Implant for Neovascular ...
Genentech's Susvimo, formerly PDS with ranibizumab, receives US FDA ...
Genentech’s new treatment for wet AMD receives FDA approval
More durable therapies for nAMD: Where we stand
SUSVIMO™ (ranibizumab injection) a Treatment Option for nAMD
SUSVIMO® (ranibizumab injection) for nAMD, DME and DR
New Indication Alert: FDA Approves Genentech’s Susvimo® (Ranibizumab ...
FDA Approves Genentech’s Susvimo, a First-of-Its-Kind Therapeutic ...
Retina Research Plays Pivotal Role in FDA Approval of Genentech’s ...
Susvimo's FDA Approval for Diabetic Retinopathy: A Paradigm Shift in ...
Susvimo: Package Insert / Prescribing Information
